Valuation Laboratorios Farmaceuticos Rovi, S.A. Wiener Boerse

Stocks

Real-time Estimate Tradegate 17:45:16 18/09/2026 +04			5-day change	1st Jan Change
58.30 ^EUR	-0.26%		+1.83%	-7.66%

07-23	Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026
07-23	Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	4,138	1,925	3,213	3,220	3,248	3,000	-	-
Change	-	-53.49%	66.93%	0.22%	0.87%	-7.65%	-	-
Enterprise Value (EV) ¹	4,112	1,872	3,251	3,305	3,272	2,991	2,927	2,814
Change	-	-54.48%	73.7%	1.65%	-1%	-8.58%	-2.14%	-3.87%
P/E	26.7x	9.67x	18.8x	23.6x	23.1x	19.8x	17.4x	14.1x
PBR	8.59x	3.71x	5.94x	5.63x	4.89x	3.98x	3.41x	2.92x
PEG	-	0.3x	-1.3x	-1.4x	7.71x	2.59x	1.3x	0.6x
Capitalization / Revenue	6.38x	2.35x	3.87x	4.22x	4.37x	3.88x	3.36x	3.07x
EV / Revenue	6.34x	2.29x	3.92x	4.33x	4.4x	3.86x	3.28x	2.88x
EV / EBITDA	20.3x	6.72x	13.3x	15.9x	15.1x	15.1x	11.4x	9.01x
EV / EBIT	22.7x	7.32x	14.8x	18.4x	17.6x	18.2x	13.2x	10.2x
EV / FCF	37.9x	10.1x	54.3x	43.5x	27.4x	23.8x	23.9x	16.9x
FCF Yield	2.64%	9.95%	1.84%	2.3%	3.65%	4.2%	4.18%	5.9%
Dividend per Share ²	0.9556	1.294	1.104	0.9351	0.9594	0.9737	1.161	1.361
Rate of return	1.29%	3.59%	1.83%	1.49%	1.51%	1.66%	1.98%	2.32%
EPS ²	2.76	3.73	3.2	2.67	2.75	2.96	3.37	4.164
Distribution rate	34.6%	34.7%	34.5%	35%	34.9%	32.9%	34.5%	32.7%
Net sales ¹	648.7	817.7	829.5	763.7	743.5	774.1	892.4	978
EBITDA ¹	202.9	278.7	244.5	207.4	216.2	197.6	257.3	312.3
EBIT ¹	181.5	255.8	220.1	179.4	185.8	164.4	222.4	275.8
Net income ¹	153.1	199.7	170.3	136.9	140.4	146.2	172.9	213.8
Net Debt ¹	-25.87	-52.78	38.6	85.1	23.84	-8.499	-72.51	-185.6
Reference price ²	73.80	36.06	60.20	62.95	63.50	58.65	58.65	58.65
Nbr of stocks (in thousands)	56,069	53,375	53,370	51,149	51,149	51,143	-	-
Announcement Date	23/02/22	21/02/23	27/02/24	25/02/25	24/02/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	32.77x	11.91x	24.15x	0.6%	1,027B
JOHNSON & JOHNSON	30.06x	6.68x	18.71x	1.99%	651B
ABBVIE INC.	33.39x	7.81x	16.15x	2.6%	467B
ROCHE HOLDING AG	19.57x	4.78x	11.84x	2.77%	350B
NOVARTIS AG	19.88x	5.19x	12.87x	3.09%	268B
ASTRAZENECA PLC	21.24x	4.38x	12.5x	2.01%	257B
AMGEN INC.	24.06x	6.34x	11.29x	2.66%	205B
NOVO NORDISK A/S	12.43x	4.52x	9.45x	4.04%	190B
GILEAD SCIENCES, INC.	-45.64x	6.64x	25.94x	2.18%	187B
Average	16.42x	6.47x	15.88x	2.44%	400.23B
Weighted average by Cap.	23.65x	7.72x	17.85x	1.99%